5-Bromo-2-Chlorobenzoic Acid CAS 21739-92-4 Dapagliflozin Intermediate Factory

Inkcazelo emfutshane:

Igama leKhemikhali: 5-Bromo-2-Chlorobenzoic Acid

CAS: 21739-92-4

Uvavanyo: ≥99.0%

Imbonakalo: Okumhlophe-kuMhlophe ukuya kwiPowder emthubi eKhanyayo

Umbindi weDapagliflozin (CAS: 461432-26-8) kunyango lwe-II yeswekile

Umgangatho ophezulu, iMveliso yoRhwebo

Inquiry: alvin@ruifuchem.com


Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo lwabavelisi, ubunyulu obuphezulu, iMveliso yoRhwebo
I-Dapagliflozin (CAS: 461432-26-8) IziPhakathi eziNxulumeneyo:
I-5-Bromo-2-Chlorobenzoic Acid CAS 21739-92-4
I-5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane CAS 461432-23-5
2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone CAS 32384-65-9

Iipropati zeMichiza:

Igama leMchiza I-5-Bromo-2-Chlorobenzoic Acid
Izithethantonye I-2-Chloro-5-Bromobenzoic Acid
Inombolo yeCAS 21739-92-4
Inombolo yeCAT RF-PI439
Ubume beStokhwe Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli C7H4BrClO2
Ubunzima beMolekyuli 235.46
Indawo yokunyibilika 154.0 ukuya 156.0℃ (lit.)
Uphawu Ruifu Chemical

Iinkcukacha:

Into Iinkcukacha
Imbonakalo I-Off-White ukuya kwiPowder eKhanyayo etyheli
Isivavanyi ≥99.0%
Amanzi (KF) ≤0.50%
Intsalela kwi-Ignition ≤0.30%
I-2-Chlorobenzoic Acid ≤0.30%
I-2-Chloro-3-Bromobenzoic Acid ≤0.30%
Ukungcola ngokupheleleyo ≤1.0%
Umgangatho woVavanyo Umgangatho woShishino
Ukusetyenziswa I-Intermediate ye-Dapagliflozin (CAS: 461432-26-8), uhlobo lwe-II yeswekile

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.

Izinto eziluncedo:

1

FAQ:

Isicelo:

I-5-Bromo-2-Chlorobenzoic Acid (i-CAS: 21739-92-4) isetyenziswe njengento yokuqala kwi-synthesis ye-Dapagliflozin (i-CAS: 461432-26-8), i-sodium-glucose cotransporter-2 inhibitor ekhethiweyo enciphisa izintso. i-glucose reabsorption kwaye isetyenziselwa ukunyanga izigulane ezine-type II yeswekile.I-Dapagliflozin inamandla kwaye ikhetha i-SGLT-2 (SLC5A2) inhibitor ene-EC50 ye-1.1 nM.Inokungena kakuhle kwiiseli zeCaco-2 kunye ne-substrate ye-P-glycoprotein (P-gp).I-Dapagliflozin yamkelwa ngo-2012 yi-FDA.

Bhala umyalezo wakho apha kwaye uwuthumele kuthi